Skip to content

A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform

CompletedNot applicableNCT03737149
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Post-market prospective, multi-center longitudinal study to determine if mobile application-guided education and exercise paired with accurate and sensitive activity monitoring, captured from consumer wearables, can provide a viable (and potentially improved) alternative to current standard of care physical therapy for hip and knee arthroplasty.

Study details

Official title
A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform
Interventions
  • Other: mymobility with Apple Watch
Sponsor
Zimmer Biomet
Start date
2018-10-22
Primary completion
2025-04-15
Sex
All
Age range
from 18 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
Australia, Italy, Netherlands, United States
Total sites listed
30

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria 1. Subject must be 18 years of age or older. 2. Subject qualifies for a primary, unilateral total or partial knee arthroplasty, based on physical exam and medical history. 3. Investigator plans to treat subject with a commercially-available device, used on-label according to the manufacturer's instructions for use, as part of their clinical care. 4. Subject owns and maintains an iPhone capable of pairing to the Apple Watch, supporting iOS updates and is compatible with the mymobility App. 5. Subject is willing and able to complete the protocol required follow-up. 6. Subject is able to read and understand the language used in the mymobility App for their region. 7. Subject is willing and able to provide written Informed Consent and Authorization by signing and dating the IRB/EC approved Informed Consent Form and Authorization. Where applicable, subject must also be willing to provide authorization for use of protected health information in accordance with local privacy laws. 8. Subject is mobile with no more than a single cane/single crutch assist preoperatively. Exclusion Criteria 1. Subject is a current alcohol or drug abuser as defined by the investigator. 2. Subject is considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.). 3. Subject has systemic inflammatory arthropathies which would interfere or compromise the activity profiles within this study. 4. Subject is currently participating in any other surgical intervention, physical therapy or pain management study which would compromise the results of this study. 5. Subject requires simultaneous or staged bilateral replacements, staged\<90 days apart. Subjects can be enrolled into the study for the second, staged arthroplasty if scheduled \>89 days after their first, contralateral replacement.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03737149